This study provides novel insights for P4HB and SOX4 diagnostic and prognostic roles in PAC that could define a subset of patients with aggressive behaviour who may require specific treatment modality via targeting both genes/proteins, leading to breakthroughs in personalised medicine in PAC patients. This evidence concerns the gene P4HB and gonorrhea.